Comparative study of the extracorporeal shock-wave therapy strength for elbow osteochondritis dissecans

Comparative study of the extracorporeal shock-wave therapy strength for elbow osteochondritis dissecans - Comparative study extracorporeal shock-wave therapy strength elbow osteochondritis dissecans

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs062260012

Enrollment

Registered

2026-05-11

Start date

2026-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Osteochondritis Dissecans Osteochondritis Dissecans

Interventions

Three individual sessions of shock wave therapy performed every 2 weeks for osteochondritis dissecans under non-anesthesia

ESWT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Meet all of the following criteria 1. Elbow osteochondritis dissecans 2. Indications for conservative therapy 3. 9 t0 15 years old when we get the patient consent 4. Attend regular check ups for 6 months

Exclusion criteria

Exclusion criteria: Meets any of the following criteria 1. Patients with loose bodies 2. Participating in or willing to participate in other clinical studies during participating this clinical study 3. Participating in the research does not constitute the greatest benefit to the research subjects. 4. The following applicable cases corresponds to taboos/prohibitions discribed attached document of DUOLITH SD1 Blood coagulation disorder Taking anticoagulants Thrombosis Malignant tumor Continuing to receive cortisone treatment more than 6 months or It has not been 6 weeks since the last injection

Design outcomes

Primary

Measure	Time frame
Repair of lesion	—

Secondary

Measure	Time frame
pain, range of motion, tenderness, pain at stress test pain and/or erythema at ESWT growth disorder	—

Contacts

Public ContactTetsuya Matsuura

Tokushima University Hospital

tmatsu@tokushima-u.ac.jp+81-88-633-9313

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026